Inducible clindamycin resistance in erythromycin-resistant, non-multiresistant, methicillin-resistant Staphylococcus aureus [7]

Pathology

Volumn 36, Issue 4, 2004, Pages 373-374

  Munckhof, Wendy J ^a   Kleinschmidt, Sharon L ^a   Schooneveldt, Jacqueline M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINCOSAMIDE; MACROLIDE; MIKAMYCIN B; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM DETECTION; GENE EXPRESSION; LABORATORY TEST; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN;

EID: 4444339071     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020410001721573     Document Type: Article

References (13)

1. Turnidge JD, Bell JM. Methicillin-resistant Staphylococcus aureus evolution in Australia over 35 years. Microb Drug Resist 2000; 6: 223-9.
2. Therapeutic Guidelines Limited. Therapeutic Guidelines: Antibiotic. Version 12, 2003. Melbourne: Therapeutic Guidelines Limited, 2003.
3. Weisblum B, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 1969; 98: 447-52.
4. Leclerq R, Courvalin P. Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991; 35: 1267-72.
5. Panagea S, Perry JD, Gould FK. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 1999; 44: 581-2.
6. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 2003; 7: 259-64.
7. Munckhof WJ, Harper J, Schooneveldt J, Nimmo GR. Recent appearance of clindamycin resistance in community-acquired methicillin-resistant Staphylococcus aureus in south-east Queensland. Med J Aust 2002; 176: 243-4.
8. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003; 22: 593-8.
9. B resistance: clinical implications. In: 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, 24-27 October 2002. Alexandria: Infectious Diseases Society of America, 2002; Abstract 91.
10. Como-Sabetti K, Glennen A, Bartkus J, et al. Inducible clindamycin resistance among erythromycin resistant community-onset methicillin-resistant Staphylococcus aureus isolates in Minnesota, 2000-2001. In: 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, 24-27 October 2002. Alexandria: Infectious Diseases Society of America, 2002; Abstract 92.
11. Frank AL, Marcinak JF, Mangat PD, Scheckenberger PC. Community acquired and clindamycin sensitive methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18: 993-1000.
12. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococccus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4.
13. Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol 1990; 4: 1207-14.